Pusterla N, Bain F, James K, Mapes S, Kenelty K, Barnett DC, Gaughan E, Craig B, Chappell DE, Vaala W.
Frequency of molecular detection of equine herpesvirus-4 in nasal secretions of 3028 horses with upper airway infection.
James KE, Smith WA, Conrad PA, Packham AE, Guerrero L, Ng M, Pusterla N
Seroprevalences of anti-Sarcocystis neurona and anti-Neospora hughesi antibodies among healthy equids in the United States.
James KE, Smith WA, Packham AE, Conrad PA, Pusterla N.
Toxoplasma gondii seroprevalence and association with equine protozoal myeloencephalitis: A case-control study of Californian horses.
Kooijman LJ, James K, Mapes SM, Theelen MJ, Pusterla N
Seroprevalence and risk factors for infection with equine coronavirus in healthy horses in the USA
Pusterla N, Hall TL, Wetzlich SE, Monmaney G, Collier JR, Hill JA, Tell LA
Pharmacokinetic parameters for single- and multi-dose regimens for subcutaneous administration of a high-dose ceftiofur crystalline-free acid to neonatal foals
Pusterla N, Magdesian KG, Mapes SM, Zavodovskaya R, Kass PH
Assessment of quantitative polymerase chain reaction for equine herpesvirus-5 in blood, nasal secretions and bronchoalveolar lavage fluid for the laboratory diagnosis of equine multinodular pulmonary fibrosis
Berryhill EH, Thomasy SM, Kass PH, Reilly CM, Good KL, Hollingsworth SR, Maggs DJ, Magdesian KG, Pusterla N
Comparison of corneal degeneration and calcific band keratopathy from 2000 to 2013 in 69 horses
Kooijman LJ, Mapes SM, Pusterla N
Development of an equine coronavirus-specific enzyme-linked immunosorbent assay to determine serologic responses in naturally infected horses
Palmero J, Hollingsworth S, Kass P, Moore S, Pusterla N
Field use of N-butylscopolammonium bromide to facilitate thorough ophthalmic examination in horses